These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 28428515)

  • 21. Phase II study of oxaliplatin plus S-1 as first-line treatment for advanced gastric cancer (G-SOX study).
    Koizumi W; Takiuchi H; Yamada Y; Boku N; Fuse N; Muro K; Komatsu Y; Tsuburaya A
    Ann Oncol; 2010 May; 21(5):1001-5. PubMed ID: 19875759
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [A case of synchronous liver metastasis originating from advanced gastric cancer treated with combination chemotherapy involving S-1 and surgical intervention].
    Takeda M; Ori T; Ohishi K; Sunayama K
    Gan To Kagaku Ryoho; 2013 May; 40(5):667-70. PubMed ID: 23863597
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [A case of pathological complete response after chemotherapy for liver metastasis with subcapsular hemorrhage from gastric cancer:].
    Goto H; Tanizawa Y; Bando E; Tokunaga M; Kawamura T; Kanemoto H; Uesaka K; Aramaki T; Yasui H; Terashima M
    Gan To Kagaku Ryoho; 2012 Sep; 39(9):1415-7. PubMed ID: 22996781
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Hepatic Resection of Multiple Liver Metastases from Gastric Cancer after Molecular Targeted Chemotherapy(S-1 plus Cisplatin plus Trastuzumab)].
    Kim Y; Hosoda Y; Nishino M; Okano M; Kawada J; Yamasaki M; Nagai K; Yasui M; Okuyama M; Tsujinaka T
    Gan To Kagaku Ryoho; 2015 Nov; 42(12):1635-7. PubMed ID: 26805121
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Feasibility study of oxaliplatin with oral S-1 or capecitabine as first-line therapy for patients with metastases from colorectal cancer.
    Watanabe K; Kawahara H; Enomoto H; Toyama Y; Akiba T; Yanaga K
    Anticancer Res; 2013 Sep; 33(9):4029-32. PubMed ID: 24023346
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [A Case of Synchronous Liver Metastasis of Ascending Colon Cancer with Pathological Complete Response to S-1/Oxaliplatin (SOX) and Bevacizumab].
    Tago T; Suzuki K; Nishida K; Maruyama T; Shimazaki J; Shimoda M; Suzuki S; Kou K; Morishita Y
    Gan To Kagaku Ryoho; 2018 May; 45(5):871-874. PubMed ID: 30026455
    [TBL] [Abstract][Full Text] [Related]  

  • 27. S-1 plus oxaliplatin versus capecitabine plus oxaliplatin for first-line treatment of patients with metastatic colorectal cancer: a randomised, non-inferiority phase 3 trial.
    Hong YS; Park YS; Lim HY; Lee J; Kim TW; Kim KP; Kim SY; Baek JY; Kim JH; Lee KW; Chung IJ; Cho SH; Lee KH; Shin SJ; Kang HJ; Shin DB; Jo SJ; Lee JW
    Lancet Oncol; 2012 Nov; 13(11):1125-32. PubMed ID: 23062232
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [A case of unresectable advanced gastric cancer successfully treated with continuous S-1 + CPT-11 chemotherapy accompanied by dose reduction against grade 4 hematological adverse event].
    Miyazaki Y; Imamura H; Kishimoto T; Furukawa H; Ota K; Tatsuta M
    Gan To Kagaku Ryoho; 2008 Nov; 35(12):2060-2. PubMed ID: 19106523
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [A case of advanced gastric cancer with multiple liver metastasis responding to S-1 and irinotecan combination therapy].
    Kuga T; Oka K; Yamashita A; Fujii Y; Hanashima M; Hamano K
    Gan To Kagaku Ryoho; 2011 Aug; 38(8):1333-6. PubMed ID: 21829075
    [No Abstract]   [Full Text] [Related]  

  • 30. [A Case of Sigmoid Colon Cancer with Synchronous Liver Metastasis, Treated with Laparoscopic Liver Resection after SOX plus BV Chemotherapy].
    Shimizu Y; Ando K; Oda K; Kubosawa H; Miyazaki M
    Gan To Kagaku Ryoho; 2015 Nov; 42(12):2163-5. PubMed ID: 26805298
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A retrospective study of S-1 and oxaliplatin combination chemotherapy in patients with refractory pancreatic cancer.
    Takahara N; Isayama H; Nakai Y; Sasaki T; Hamada T; Uchino R; Mizuno S; Miyabayashi K; Kogure H; Yamamoto N; Sasahira N; Hirano K; Ijichi H; Tateishi K; Tada M; Koike K
    Cancer Chemother Pharmacol; 2013 Nov; 72(5):985-90. PubMed ID: 23995699
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of Conversion Surgery Following S-1 plus Cisplatin or Oxaliplatin Chemotherapy for Unresectable Gastric Cancer.
    Fukuchi M; Mochiki E; Ishiguro T; Ogura T; Sobajima J; Kumagai Y; Ishibashi K; Ishida H
    Anticancer Res; 2017 Mar; 37(3):1343-1347. PubMed ID: 28314301
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [A case of advanced gastric cancer which became operable after chemotherapy with combination of TS-1/CDDP and in which complete disappearance of liver metastasis was histopathologically confirmed].
    Meguro E; Kaizuka H; Inaba T; Irinoda T; Hayakawa Y; Okada S; Yamaguchi S; Wakabayashi J
    Gan To Kagaku Ryoho; 2003 Jun; 30(6):863-7. PubMed ID: 12852358
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [A case report of bi-weekly docetaxel and S-1 combination chemotherapy for gastric cancer with multiple liver metastases and esophageal invasion].
    Matsuda S; Takahashi M; Watanabe J; Yabuno T; Mochizuki Y; Kito F; Kunisaki C
    Gan To Kagaku Ryoho; 2010 Jul; 37(7):1353-6. PubMed ID: 20647726
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Complete Response Obtained with S-1 Plus CDDP Therapy in a Patient with Multiple Liver Metastases from Gastric Cancer.
    Nonoshita T; Otsuka S; Inagaki M; Iwagaki H
    Hiroshima J Med Sci; 2015 Dec; 64(4):65-9. PubMed ID: 26964156
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Meta-analysis supporting noninferiority of oxaliplatin plus S-1 to cisplatin plus S-1 in first-line treatment of advanced gastric cancer (G-SOX study): indirect comparison with S-1 alone.
    Hamada C; Yamada Y; Azuma M; Nishikawa K; Gotoh M; Bando H; Sugimoto N; Nishina T; Amagai K; Chin K; Niwa Y; Tsuji A; Imamura H; Tsuda M; Yasui H; Fujii H; Yamaguchi K; Yasui H; Hironaka S; Shimada K; Miwa H; Hyodo I
    Int J Clin Oncol; 2016 Aug; 21(4):668-675. PubMed ID: 26733020
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Leucovorin, fluorouracil, and oxaliplatin plus bevacizumab versus S-1 and oxaliplatin plus bevacizumab in patients with metastatic colorectal cancer (SOFT): an open-label, non-inferiority, randomised phase 3 trial.
    Yamada Y; Takahari D; Matsumoto H; Baba H; Nakamura M; Yoshida K; Yoshida M; Iwamoto S; Shimada K; Komatsu Y; Sasaki Y; Satoh T; Takahashi K; Mishima H; Muro K; Watanabe M; Sakata Y; Morita S; Shimada Y; Sugihara K
    Lancet Oncol; 2013 Dec; 14(13):1278-86. PubMed ID: 24225157
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [A Case Report of Long-Term Survival after SOX Chemotherapy for Metastatic Ovarian Tumor of Gastric Cancer].
    Yamada M; Nakai K; Inoue K; Hijikawa T; Hachimine T; Yasuda K; Uemura Y; Yoshioka K; Kon M
    Gan To Kagaku Ryoho; 2017 Oct; 44(10):941-943. PubMed ID: 29066703
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phase I clinical and pharmacokinetic/pharmacogenetic study of a triplet regimen of S-1/irinotecan/oxaliplatin in patients with metastatic colorectal or gastric cancer.
    Park SR; Hong YS; Lim HS; Seong MW; Kong SY; Kim SY; Park YI; Jung KH
    Cancer Chemother Pharmacol; 2013 Nov; 72(5):953-64. PubMed ID: 23982118
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sex differences in the safety of S-1 plus oxaliplatin and S-1 plus cisplatin for patients with metastatic gastric cancer.
    Yamada Y; Koizumi W; Nishikawa K; Gotoh M; Fuse N; Sugimoto N; Nishina T; Amagai K; Chin K; Niwa Y; Tsuji A; Imamura H; Tsuda M; Yasui H; Fujii H; Yamaguchi K; Yasui H; Hironaka S; Shimada K; Hyodo I
    Cancer Sci; 2019 Sep; 110(9):2875-2883. PubMed ID: 31254422
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.